A Phase 4 Study to Evaluate Glucodynamic Effects of Dulaglutide in Japanese Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 16 Aug 2018
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 09 Mar 2018 Status changed from active, no longer recruiting to completed.
- 27 Feb 2018 Planned End Date changed from 19 Mar 2018 to 28 Feb 2018.